BillionToOne (BLLN) CTO logs 20K share sale and option exercise under 10b5-1 plan
Rhea-AI Filing Summary
BillionToOne, Inc. director and Chief Technology Officer David Tsao reported a mix of stock sales and option exercises in Class A Common Stock. He completed open-market sales totaling 20,000 shares on June 15, 2026 at weighted average prices generally around $100–$104 per share, in multiple tranches.
On the same date, he exercised stock options to acquire 20,000 shares at an exercise price of $2.80 per share. After these transactions, Tsao directly holds 19,296 shares of Class A Common Stock and 630,000 stock options with a $2.80 exercise price expiring on June 7, 2031. The filing states the transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 10,000 | $2.80 | $28K |
| Exercise | Stock Option (right to buy) | 10,000 | $2.80 | $28K |
| Exercise | Class A Common Stock | 10,000 | $2.80 | $28K |
| Exercise | Class A Common Stock | 10,000 | $2.80 | $28K |
| Sale | Class A Common Stock | 1,704 | $100.3718 | $171K |
| Sale | Class A Common Stock | 2,361 | $101.5524 | $240K |
| Sale | Class A Common Stock | 2,816 | $102.7739 | $289K |
| Sale | Class A Common Stock | 2,889 | $103.6843 | $300K |
| Sale | Class A Common Stock | 230 | $104.472 | $24K |
| Sale | Class A Common Stock | 600 | $98.7417 | $59K |
| Sale | Class A Common Stock | 1,000 | $100.053 | $100K |
| Sale | Class A Common Stock | 2,461 | $101.3707 | $249K |
| Sale | Class A Common Stock | 2,978 | $102.5988 | $306K |
| Sale | Class A Common Stock | 2,398 | $103.6289 | $249K |
| Sale | Class A Common Stock | 563 | $104.3167 | $59K |
Footnotes (13)
- F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.000 to $100.9175 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.120 to $102.020 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.185 to $103.150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.250 to $104.200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.360 to $104.610 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.160 to $99.080 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.840 to $100.280 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.860 to $101.800 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.980 to $102.970 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.140 to $104.130 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.160 to $104.540 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13. The options are fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (right to buy) financial
Class A Common Stock financial
derivative exercise/conversion financial
FAQ
What did BillionToOne (BLLN) CTO David Tsao report in this Form 4?
What options did BillionToOne (BLLN) CTO David Tsao exercise in this filing?
What are David Tsao’s BillionToOne (BLLN) holdings after these transactions?
Were David Tsao’s BillionToOne (BLLN) stock sales pre-planned?
What is the significance of the weighted average prices in the BLLN Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.